Labat AfricaJSE:LAB +66.67% Market Cap is R113.3 Mil as of Jun. 25, 2026. The stock has 5 warning signs investors should review. Among 1,023 Drug Manufacturers companies, Labat Africa ranks worse than 87.88% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Labat Africa's share price for the quarter that ended in Nov. 2025 was R0.05. Labat Africa's Shares Outstanding (EOP) for the quarter that ended in Nov. 2025 was 1,246.1 Mil. Therefore, Labat Africa's market cap for the quarter that ended in Nov. 2025 was R62.3 Mil.
Labat Africa's quarterly market cap
increased
from Nov. 2024 (R45.5 Mil) to May. 2025 (R79.1 Mil) but then
declined
from May. 2025 (R79.1 Mil) to Nov. 2025 (R62.3 Mil).
Labat Africa's annual market cap
declined
from Aug. 2021 (R110.3 Mil) to May. 2023 (R43.4 Mil) but then
increased
from May. 2023 (R43.4 Mil) to May. 2024 (R45.5 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Labat Africa's Enterprise Value for Today is R255.6 Mil.
Labat Africa (JSE:LAB) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Labat Africa Market Cap Related Terms
Labat Africa Market Cap Historical Data
* Premium members only.
The historical data trend for Labat Africa's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Labat Africa's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Labat Africa Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Labat Africa's Market Cap distribution charts can be found below:
* The bar in red indicates where Labat Africa's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Labat Africa's Market Cap for the fiscal year that ended in May. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Labat Africa (JSE:LAB) has a Market Cap of R113.3 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Labat Africa and its competitors. According to the industry distribution chart, Labat Africa ranks #899 out of 1023 companies in the Drug Manufacturers industry, placing it in the top 87.9%.
Is Labat Africa's Market Cap too high?
Labat Africa's current Market Cap is R113.3 Mil. Based on the distribution chart, Labat Africa ranks #899 out of 1023 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Labat Africa's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Labat Africa ranks #899 out of 1023 companies for Market Cap. This places Labat Africa in the lower half of its industry. The industry median Market Cap is 206.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 206.50, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Labat Africa and its competitors. For the Drug Manufacturers industry, the median Market Cap is 206.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Labat Africa's current Market Cap is R113.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labat Africa stock overvalued right now?
Based on GuruFocus' analysis, Labat Africa (JSE:LAB) is currently considered Possible Value Trap. The stock's GF Value™ is R0.22, compared to a current price of R0.05 — trading 77.3% below its estimated fair value. The current Market Cap is R113.3 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Labat Africa (JSE:LAB), the current Market Cap is R113.3 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Labat Africa Ltd is an investment holding company. Through its subsidiaries, the company operates in the following segments; Technology, Head office, and Healthcare. The Technology segment manufactures and distributes integrated circuits South African Micro - Electronic Systems. Head office operations provide management services, logistics and seeks further investment opportunities for the Group. The Healthcare segment generates maximum revenue for the company and focusses on medical cannabis industry in South Africa. Geographically, the company carries out its business operations in South Africa.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:LAB has been successfully added to your 